Equillium, Inc. (EQ): Nasdaq/NYSE listing notice — Equillium receives Nasdaq minimum bid price non-compliance notice; cure period until June 11, 2025

Equillium, Inc.

Nasdaq notified Equillium on Dec 13, 2024 that common stock bid price was below $1.00 for 30 consecutive business days.
Company has 180 calendar days, until June 11, 2025, to regain compliance with the Minimum Bid Price Requirement.
To cure, minimum bid must close at $1.00 or higher for at least ten consecutive business days during the grace period.
If not cured by June 2025, Equillium may qualify for a second 180-day compliance period if it meets other listing standards.
Equillium intends to monitor bid price and is considering options such as a reverse stock split to regain compliance.

item 3.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.98

Equillium, Inc. received a nasdaq noncompliance notice notice regarding minimum bid price (rules 5550(a)(2)).

Exchange: nasdaq
Notice: noncompliance notice
Deficiency: minimum bid price
Rules: 5550(a)(2)

Exact text from the filing

December 13, 2024, Equillium, Inc. (the “Company”) received a notice from The Nasdaq Stock Market (“Nasdaq”) that the Company is not in compliance with Nasdaq’s Listing Rule 5550(a)(2), as the minimum bid price of the Company’s common stock has been below $1.00 per share for 30 consecutive business days (the “Minimum Bid Price Requirement”). The notification of noncompliance has no immediate effect on the listing or trading of the Company’s common stock on The Nasdaq Capital Market and the Company’s common stock continues to trade on the Nasdaq Capital Market under the symbol “EQ.” Under Nasda

View on SEC.gov

Browse all listing & compliance notices →

Equillium, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-24-278465

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.